R&D | April 23, 2026
Sanplatec selects Mitsubishi Chemical’s Zelas TPS for new cell culture tubes
Sanplatec is leading the industry in the field of containers and devices for cell culture and live transport
Sanplatec is leading the industry in the field of containers and devices for cell culture and live transport
Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
The system is powered by BrainSense technology, which has received approval from USFDA
The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations
While many cases are treatable, a subset can become highly aggressive, spreading to distant organs and resisting conventional therapies
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
Pharma giant targets new standards of care
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
